AIRAmed
PrivateLast Round
Accelerator
Oct 29, 2020
Company Overview
AIRAmed is a medical technology company that develops AI-powered software for the quantitative analysis of neuroradiological MRI image data to assist in the early detection and monitoring of neurodegenerative diseases.
Sector
Healthcare & Life Sciences
Verticals
Medical Imaging, Medical AI, Healthcare Analytics, Computer Vision
Business Model
B2B
Customer Profile
Subscription SaaS, Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AIRAmed Comparables
Compare AIRAmed with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Brainreader | 92% | |
| mediaire | 87% | |
| In-Med Prognostics | 86% |
AIRAmed Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Oct 29, 2020 |
Key People
Founding team and executive leadership
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 29, 2024
Monthly visitors grew 570% MoM, reaching 13.4K.
- Jun 17, 2024
Grew 32% QoQ, from 19 to 25 employees.
AIRAmed Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about AIRAmed's valuation, stock price, and market status.
Is AIRAmed a public or private company?
AIRAmed is a private company.
What is the current stock price of AIRAmed?
AIRAmed is a private company with no public stock price. No recent secondary market data is available.
How much is AIRAmed worth (valuation)?
Valuation information for AIRAmed is not publicly available.
Can I buy AIRAmed stock?
AIRAmed shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was AIRAmed's last funding round?
AIRAmed's most recent funding round was Accelerator on October 29, 2020.
Who are the main investors in AIRAmed?
Investor information for AIRAmed is not publicly disclosed.
Will AIRAmed IPO soon?
No public IPO plans have been announced for AIRAmed.
How can I track AIRAmed secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor AIRAmed's secondary market activity and sign up for updates.